Suscribirse

Survival and complications of total hip arthroplasty using third-generation dual-mobility cups with non-cross-linked polyethylene liners in patients younger than 55 years - 13/04/22

Doi : 10.1016/j.otsr.2022.103208 
Chloé Viricel a, , Bertrand Boyer a, b, Rémi Philippot a, c, Frédéric Farizon a, b, Thomas Neri a, c
a Service de chirurgie orthopédique et traumatologique, centre hospitalo-universitaire de Saint-Étienne, Hôpital Nord, 42055 Saint-Étienne, France 
b INSERM U1059 (SAINBIOSE), Université Jean-Monnet, Saint-Étienne, France 
c EA 7424, Inter-university Laboratory of Human Movement Science, Université de Lyon – Université Jean-Monnet, Saint-Étienne, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

In younger patients, total hip prostheses are subjected to wide motion ranges and wear-inducing forces. Dual-mobility cups (DMCs) are effective in decreasing the risk of dislocation. However, wear and osteolysis have been reported with first-generation DMCs. These complications have not been assessed in younger patients managed with third-generation DMCs associated with a lower risk of intra-prosthetic dislocation (IPD). We therefore designed a retrospective study of patients younger than 55years at THA with third-generation DMCs. Our objectives were to evaluate (1) the complication rate, and (2) the survival rate.

Hypothesis

The rate of complications of THA with third-generation DMCs in patients younger than 55years of age is comparable to that in the general population of THA patients.

Material and methods

This retrospective study included 79 consecutive patients (91 hips) who had total hip arthroplasty (THA) between 2007 and 2012. We included all patients younger than 55years who underwent primary THA with a third-generation DMC and a liner made of non-cross-linked polyethylene. The patients were evaluated clinically and radiologically.

Results

Mean follow-up was 9.8years (range: 2–13years). At last follow-up, no patient had experienced prosthetic dislocation or IPD. Aseptic and septic cup loosening each occurred in 1 patient. In all, 7 (7.7%) patients required revision surgery with exchange of at least one component (cup loosening, n=2; neck fracture with a short stem fixed to the neck, n=1; peri-prosthetic femoral fracture, n=1; infection, n=1; and femoral-stem loosening, n=2). Peri-acetabular osteolysis developed in 2 (2.2%) hips. Cup survival to aseptic loosening was 98.9% (95% confidence interval, 97%–100%) and survival to revision for any reason except infection was 95.6% (95% confidence interval, 82%–100%).

Discussion

In patients younger than 55years, third-generation DMCs were associated with absence of prosthetic dislocation, absence of IPD, and a low revision rate for cup loosening, in the medium term. These implants therefore constitute a viable treatment option in younger patients requiring THA.

Level of evidence

IV, retrospective study.

El texto completo de este artículo está disponible en PDF.

Keywords : Dual-mobility cup, Age less than 55years, Total hip arthroplasty, Survival


Esquema


© 2022  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 108 - N° 2

Artículo 103208- avril 2022 Regresar al número
Artículo precedente Artículo precedente
  • The significant relationship among the factors of pelvic incidence, standing lumbar lordosis, and lumbar flexibility in Japanese patients with hip osteoarthritis: A descriptive radiographic study
  • Takaomi Kobayashi, Tadatsugu Morimoto, Tomohito Yoshihara, Motoki Sonohata, Charles Rivière, Masaaki Mawatari
| Artículo siguiente Artículo siguiente
  • Cementless hydroxyapatite-coated stem with dual mobility and posterior approach in over-80 year-old patients with osteoarthritis: Rates of dislocation and periprosthetic fracture at a mean 8 years’ follow-up
  • Vincent Belgaïd, Anthony Viste, Michel-Henri Fessy

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.